CBIO Crescent Biopharma, Inc. - Common Stock
$17,40
Prix · Aoû 19, 2026
Données fondamentales au Jul 30, 2026
Fourchette 52 semaines
$9–$27
46% of range
Note des analystes
BUY
15 analysts
Objectif de cours
$31
+76% upside
P/E (TTM)
-35.5
ROE
-90.0%
Marge nette
-1419.6%
CBIO Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$17.39
Capitalisation Boursière
$480M
P/E (TTM)
-35.5
BPA (TTM)
$-0.59
Revenus (TTM)
$11M
Rendement div.
—
ROE
-90.0%
Dette/Capitaux propres
—
Fourchette 52 semaines
$9 – $27
CBIO Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$11M
2016-12-31
→
2025-12-31
BPA
$-0.59
2019-12-31
→
2024-12-31
Flux de trésorerie libre
$-72M
2016-12-31
→
2025-12-31
Marges
-1419.6%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
CBIO
Médiane des pairs
P/E (TTM)
-35.5
19.6
P/S (TTM)
44.2
6.4
P/B
2.4
2.6
Price / FCF (Cours / FCF)
-6.6
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
CBIO
Médiane des pairs
Operating Margin (Marge d'exploitation)
-1407.5%
—
Net Profit Margin (Marge nette)
-1419.6%
-104.2%
ROA
-111.6%
-40.3%
ROE
-90.0%
-42.4%
ROIC
-76.2%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
CBIO
Médiane des pairs
Current Ratio (Ratio de liquidité)
6.6
5.4
Quick Ratio (Ratio de liquidité réduite)
6.4
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
CBIO
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
-86.7%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
424.9%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
1.3%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
CBIO
Médiane des pairs
Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans
Rendement du Dividende
—
Ratio de distribution
—
CAGR des dividendes sur 5 ans
—
| Date ex-dividende | Montant |
|---|---|
| 13 janvier 2023 | $24,0000 |
| 21 septembre 2022 | $143,0000 |
CBIO Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
15 analystes
- Achat fort 6 40,0%
- Achat 7 46,7%
- Conserver 2 13,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
5 analystes · 2026-08-19
Médiane
$28.00
Moyenne
$30.60
← En dessous de tous les objectifs
$17.39
Bas
$27.00
Haut
$35.00
Objectif médian
$28.00
+61,0%
Objectif moyen
$30.60
+75,9%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.18%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $-0.74 | $-0.81 | 0.07% |
| 31 mars 2026 | $-0.70 | $-0.97 | 0.27% |
| 31 décembre 2025 | $-0.54 | $-2.57 | 2.0% |
| 30 septembre 2025 | $-1.27 | $-2.02 | 0.75% |
| 30 juin 2025 | $-4.93 | $-1.80 | -3.1% |
| 31 mars 2025 | $-4.00 | $-5.10 | 1.1% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| R&D Expense | $138M | $14M | $20M | $28M | $47M | $45M | $47M | $40M | $24M | $23M | $25M | $20M | |
| SG&A Expense | $25M | $18M | $19M | $19M | $17M | $17M | $14M | $11M | $10M | $9M | $8M | $7M | |
| Operating Expenses | $163M | $40M | $39M | $47M | $65M | $62M | $61M | $52M | $34M | $32M | $33M | $26M | |
| Operating Income | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M | |
| Other Non-op | · | $2M | $2M | · | · | · | · | · | $651.2K | $103.6K | $15.3K | $18.2K | |
| Pretax Income | $-152M | · | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| EPS (Basic) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| EPS (Diluted) | · | $-0.59 | $-0.58 | $-0.89 | $-1.23 | $-1.12 | $-1.34 | · | · | · | · | $-0.60 | |
| Shares (Basic) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| Shares (Diluted) | · | 64,477,249 | 63,342,465 | 52,531,173 | 51,453,204 | 45,721,139 | 43,254,782 | · | · | · | · | 18,452,252 | |
| EBITDA | $-153M | $-40M | $-39M | $-47M | $-63M | $-52M | $-61M | $-52M | $-34M | $-32M | $-13M | $-11M |
Bilan 21
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $213M | $35M | $42M | $48M | $90M | $137M | $158M | $210M | $124M | $40M | $47M | $55M | |
| Receivables | $18M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $5M | $38.0K | $2M | $3M | $533.8K | $1M | $4M | $2M | $3M | $478.5K | $441.8K | $916.2K | |
| Other Current Assets | $5M | $38.0K | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $237M | $35M | $44M | $51M | $91M | $138M | $163M | $212M | $127M | $41M | $47M | $56M | |
| PP&E (Net) | $846.0K | $0 | · | $242.4K | $368.8K | $620.7K | $822.9K | $957.2K | $1M | $1M | $521.4K | $452.3K | |
| PP&E (Gross) | · | · | · | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | |
| Accum. Depreciation | · | · | · | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $902.1K | $905.5K | |
| Other Non-current Assets | $1M | $813.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Accounts Payable | · | $329.3K | $868.1K | $970.2K | $2M | $2M | $1M | $3M | $3M | $2M | $564.2K | $874.0K | |
| Accrued Liabilities | $16M | $2M | $5M | $7M | $9M | $9M | $9M | $6M | $4M | $3M | $6M | $5M | |
| Current Liabilities | $36M | $10M | $7M | $9M | $12M | $12M | $11M | $9M | $8M | $6M | $8M | $6M | |
| Capital Leases | $1M | $0 | $66.8K | · | $918.6K | $2M | $3M | · | · | · | · | · | |
| Total Liabilities | $37M | $47M | $7M | $9M | $13M | $15M | $14M | $9M | $9M | $7M | $8M | $6M | |
| Common Stock | $28.0K | $1.0K | $64.4K | $54.4K | $52.3K | $49.0K | $43.5K | $43.2K | $34.4K | $23.2K | $19.0K | $18.9K | |
| Paid-in Capital | $371M | $2M | $495M | $462M | $454M | $438M | $413M | $406M | $272M | $154M | $128M | $125M | |
| Retained Earnings | $-172M | $-18M | $-456M | $-420M | $-373M | $-309M | $-258M | $-201M | $-152M | $-119M | $-87M | $-74M | |
| Stockholders' Equity | $203M | $-15M | $38M | $43M | $82M | $128M | $154M | $205M | $120M | $35M | $40M | $51M | |
| Liabilities + Equity | $240M | $36M | $45M | $52M | $94M | $143M | $168M | $215M | $129M | $42M | $48M | $57M | |
| Shares Outstanding | 27,556,767 | 1,018,604 | 64,393,744 | 54,377,798 | 52,313,894 | 49,017,622 | 43,466,933 | 43,160,751 | 34,359,799 | 23,250,023 | 19,050,204 | 18,939,838 |
Flux de trésorerie 11
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $5M | $4M | $4M | $6M | $7M | $6M | $5M | $4M | $3M | $2M | $2M | |
| Deferred Tax | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | $7M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-72M | $-31M | $-35M | $-46M | $-57M | $-39M | $-52M | $-43M | $-30M | $-30M | $-8M | $-4M | |
| CapEx | $919.0K | $10.0K | $21.4K | $84.2K | $14.9K | $68.5K | $144.9K | $125.6K | $294.1K | $704.2K | $268.6K | $212.6K | |
| Investing Cash Flow | $-73M | $20.0K | $-21.4K | $-84.2K | $-14.9K | $-68.5K | $-144.9K | $-125.6K | $-294.1K | $-704.2K | $-268.6K | · | |
| Stock Issued | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Net Stock Activity | $0 | · | $29M | $4M | $11M | $18M | · | $128M | $114M | $24M | · | $57M | |
| Financing Cash Flow | $323M | $5.4K | $29M | $4M | $11M | $18M | $412.9K | $129M | $114M | $24M | $114.1K | · | |
| Net Change in Cash | $179M | $-31M | $-6M | $-42M | $-47M | $-21M | $-52M | $86M | $84M | $-7M | $-8M | $53M | |
| Free Cash Flow | $-72M | $-31M | $-35M | $-47M | $-58M | $-39M | $-52M | $-43M | $-30M | $-30M | $-9M | $-4M |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| Net Margin | -1419.6% | · | -368994.2% | -62251.7% | -5469.0% | -502.1% | · | · | · | -171945.1% | -63.6% | -74.0% | |
| Pretax Margin | -1401.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1407.5% | · | -392752.9% | -63204.4% | -5470.7% | -506.8% | · | · | · | -172505.3% | -63.7% | -74.1% | |
| ROA | -111.6% | -134.3% | -76.0% | -63.9% | -53.5% | -32.8% | -30.2% | -28.1% | -38.9% | -70.0% | -24.2% | -35.6% | |
| ROE | -90.0% | -1888.5% | -86.9% | -102.6% | -71.2% | -38.3% | -36.0% | -22.8% | -42.9% | -84.0% | -28.0% | -41.4% | |
| ROIC | -76.2% | · | · | · | · | · | · | · | · | · | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 | 11.1 | 14.8 | 24.2 | 15.6 | 6.4 | 6.1 | 8.7 | |
| Quick Ratio | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 | 11.0 | 14.4 | 24.0 | 15.2 | 6.3 | 6.0 | 8.5 |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | 0.0 | 0.0 | 0.1 | · | · | · | 0.0 | 0.4 | 0.5 | |
| Receivables Turnover | 1.2 | · | · | · | · | · | · | · | · | · | · | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -86.7% | -93.5% | -88.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 424.9% | · | -90.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.3% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | · | $10.0K | $75.0K | $1M | $10M | · | · | · | $18.5K | $20M | $15M | |
| Net Income TTM | $-154M | $-38M | $-37M | $-47M | $-63M | $-51M | $-58M | $-48M | $-33M | $-32M | $-13M | $-11M | |
| Market Cap | $327M | $1.61B | $15.20B | $16.48B | $7.53B | $18.43B | $22.99B | $40.87B | $57.69B | $14.18B | $10.90B | $13.64B | |
| P/E | -24.2 | -42.4 | -406.9 | -340.4 | -117.1 | -335.7 | -394.8 | -1262.7 | -2238.7 | -813.3 | -805.6 | -1200.0 | |
| P/S | 30.1 | · | 1519692.4 | 219686.3 | 6495.4 | 1813.5 | · | · | · | 766622.4 | 542.9 | 907.5 | |
| P/B | 1.6 | 303.4 | 395.6 | 383.8 | 92.3 | 143.7 | 149.1 | 198.9 | 481.9 | 401.8 | 269.2 | 268.4 | |
| P / Tangible Book | 1.6 | · | 395.6 | 383.8 | 92.3 | 143.7 | · | · | · | · | · | · | |
| P / Cash Flow | -4.6 | -51.8 | -435.7 | -354.7 | -131.0 | -469.7 | -442.3 | -943.3 | -1938.0 | -477.0 | -1322.1 | -3185.0 | |
| P / FCF | -4.5 | -51.8 | -435.4 | -354.0 | -131.0 | -468.8 | -441.1 | -940.5 | -1919.0 | -466.0 | -1280.4 | -3034.3 | |
| Earnings Yield | -4.1% | -2.4% | -0.25% | -0.29% | -0.85% | -0.30% | -0.25% | -0.08% | -0.04% | -0.12% | -0.12% | -0.08% |
Compte de résultat 13
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | $0 | · | |
| R&D Expense | $19M | $18M | $106M | $20M | $12M | $11M | $233.2K | $2M | $6M | $6M | $5M | $5M | $4M | $5M | $6M | $5M | |
| SG&A Expense | $9M | $8M | $9M | $6M | $9M | $4M | $5M | $4M | $4M | $5M | $4M | $5M | $5M | $6M | $5M | $4M | |
| Operating Expenses | $28M | $26M | $114M | $26M | $21M | $14M | $7M | $11M | $10M | $11M | $10M | $10M | $9M | $11M | $11M | $9M | |
| Operating Income | $-26M | $-25M | $-103M | $-26M | $-21M | $-14M | $-7M | $-11M | $-10M | $-11M | $-10M | $-10M | $-9M | $-11M | $-11M | $-9M | |
| Other Non-op | $2M | $1M | · | $1M | $-760.0K | $-924.0K | $110.1K | $1M | · | · | $512.2K | $611.0K | · | · | · | · | |
| Income Tax | $0 | $0 | $2M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-25M | $-23M | $-23M | $-25M | $-22M | $-15M | $-7M | $-10M | $-10M | $-11M | $-9M | $-9M | $-8M | $-10M | $-10M | $-9M | |
| EPS (Basic) | · | · | · | · | · | $-0.04 | $-0.11 | $-0.15 | $-0.16 | $-0.17 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| EPS (Diluted) | · | · | · | · | · | · | $-0.24 | $-0.15 | $-0.16 | $-0.04 | $-0.14 | $-0.14 | $-0.13 | $-0.17 | $-0.20 | $-0.16 | |
| Shares (Basic) | · | · | · | · | · | 64,522,257 | -128,947,790 | 64,483,958 | 64,483,848 | 64,457,233 | -125,633,555 | 64,349,709 | 64,276,184 | 60,350,127 | -104,631,509 | 52,423,944 | |
| Shares (Diluted) | · | · | · | · | · | · | -129,012,814 | 64,483,958 | 64,483,848 | 64,522,257 | -129,740,661 | 64,349,709 | 64,276,184 | 64,457,233 | -104,631,509 | 52,423,944 | |
| EBITDA | $-26M | · | · | $-26M | $-21M | $-2M | · | $-11M | $-10M | $-11M | · | $-10M | $-9M | $-11M | · | $-9M |
Bilan 21
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $172M | $189M | $213M | $133M | $153M | $6M | $11M | $14M | $22M | $31M | $42M | $49M | $58M | $65M | $48M | $52M | |
| Receivables | $0 | $0 | $18M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $7M | $6M | $5M | $1M | $2M | $378.0K | $371.3K | $1M | $1M | $2M | $2M | $3M | $2M | $3M | $3M | $2M | |
| Other Current Assets | $7M | $6M | $5M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $179M | $196M | $237M | $135M | $154M | $6M | $11M | $16M | $24M | $33M | $44M | $52M | $60M | $68M | $51M | $54M | |
| PP&E (Net) | $876.0K | $929.0K | $846.0K | $782.0K | $193.0K | · | · | · | · | · | · | $133.0K | $167.9K | $200.7K | · | $288.1K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | · | $2M | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Accounts Payable | · | · | · | · | · | $104.7K | $329.3K | $581.8K | $950.8K | $755.5K | $868.1K | $329.9K | $241.5K | $480.2K | $970.2K | $852.1K | |
| Accrued Liabilities | $7M | $4M | $16M | $9M | $8M | $3M | $5M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $7M | $6M | |
| Current Liabilities | $19M | $14M | $36M | $20M | $17M | $3M | $6M | $4M | $4M | $5M | $7M | $6M | $7M | $7M | $9M | $8M | |
| Capital Leases | $966.0K | $1M | $1M | $1M | $1M | · | · | · | · | · | $66.8K | $262.1K | $448.8K | · | · | $95.6K | |
| Total Liabilities | $20M | $15M | $37M | $22M | $18M | $3M | $6M | $4M | $4M | $5M | $7M | $7M | $7M | $7M | $9M | $8M | |
| Common Stock | $28.0K | $28.0K | $28.0K | $14.0K | $14.0K | $64.5K | $64.5K | $64.5K | $64.5K | $64.5K | $64.4K | $64.4K | $64.3K | $64.2K | $54.4K | $52.4K | |
| Paid-in Capital | $379M | $375M | $371M | $192M | $190M | $500M | $500M | $498M | $497M | $496M | $495M | $494M | $493M | $492M | $462M | $457M | |
| Retained Earnings | $-220M | $-195M | $-172M | $-79M | $-55M | $-497M | $-494M | $-487M | $-477M | $-467M | $-456M | $-447M | $-438M | $-430M | $-420M | $-409M | |
| Stockholders' Equity | $163M | $184M | $203M | $117M | $139M | $3M | $5M | $11M | $20M | $29M | $38M | $47M | $55M | $62M | $43M | $48M | |
| Liabilities + Equity | $183M | $199M | $240M | $138M | $157M | $6M | $11M | $16M | $24M | $34M | $45M | $53M | $62M | $69M | $52M | $56M | |
| Shares Outstanding | 27,756,044 | 27,571,935 | 27,556,767 | 13,892,516 | 13,892,562 | 64,532,091 | 64,483,958 | 64,483,958 | 64,483,958 | 64,450,835 | 64,393,744 | 64,368,843 | 64,313,333 | 64,245,224 | 54,377,798 | 52,423,944 |
Flux de trésorerie 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $2M | $6M | $1M | $1M | $1M | $1M | $1M | $908.4K | $887.8K | $858.1K | $870.2K | $899.2K | $914.0K | |
| Restructuring | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-19M | $-9M | $-27M | $-18M | $-22M | $-11M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $-12M | $-8M | $-9M | |
| CapEx | $13.0K | $147.0K | $193.0K | $586.0K | $140.0K | $0 | $0 | $0 | $2.5K | $7.4K | $801 | $7.9K | $10.5K | $2.2K | $1 | $2.5K | |
| Investing Cash Flow | $2M | $-8M | $-72M | $-586.0K | $-140.0K | $0 | $30.0K | $0 | $-2.5K | $-7.4K | $-801 | $-7.9K | $-10.5K | $-2.2K | $-1 | $-2.5K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $29M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $29M | · | · | |
| Financing Cash Flow | $136.0K | $-7M | $179M | $-1M | $147M | $-1M | $0 | $0 | $500 | $4.9K | $999 | $61.6K | $20.1K | $29M | · | · | |
| Net Change in Cash | $-18M | $-24M | $80M | $-19M | $123M | $-12M | $-4M | $-8M | $-9M | $-11M | $-8M | $-9M | $-7M | $17M | $-4M | $-9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-11M | · | · | · | $-12M | · | · |
Rentabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.6% | · | · | -32.0% | -24.0% | -11.7% | · | -28.5% | -23.4% | -20.8% | · | -16.9% | -13.0% | -13.8% | · | -10.4% | |
| ROE | -16.4% | · | · | -38.4% | -27.4% | -14.5% | · | -33.9% | -27.0% | -23.6% | · | -19.4% | -14.9% | -15.9% | · | -11.8% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.7 | · | · | 6.6 | 9.2 | 2.3 | · | 3.6 | 5.5 | 6.3 | · | 8.1 | 9.2 | 10.1 | · | 6.9 | |
| Quick Ratio | 9.3 | · | · | 6.6 | 9.1 | 2.1 | · | 3.3 | 5.1 | 5.9 | · | 7.7 | 8.8 | 9.6 | · | 6.7 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-96M | $-93M | · | $-71M | $-57M | $-46M | · | $-40M | $-38M | $-39M | · | $-36M | $-40M | $-47M | · | $-54M | |
| Market Cap | $500M | · | · | $165M | $224M | $1.36B | · | $1.10B | $1.81B | $19.34B | · | $9.66B | $11.19B | $8.09B | · | $2.88B | |
| P/E | -36.7 | -37.5 | · | -24.3 | -32.9 | -42.9 | · | -34.7 | -59.6 | -625.0 | · | -250.0 | -245.1 | -146.5 | · | -53.4 | |
| P/B | 3.1 | · | · | 1.4 | 1.6 | 401.5 | · | 96.4 | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Tangible Book | 3.1 | 2.8 | · | 1.4 | 1.6 | 401.5 | · | 96.4 | 90.0 | 668.8 | · | 207.4 | 204.2 | 130.2 | · | 59.9 | |
| P / Cash Flow | · | · | · | · | · | -265.4 | · | · | · | -1839.9 | · | · | · | -697.4 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -1838.6 | · | · | · | -697.3 | · | · | |
| Earnings Yield | -2.7% | -2.7% | · | -4.1% | -3.0% | -2.3% | · | -2.9% | -1.7% | -0.16% | · | -0.40% | -0.41% | -0.68% | · | -1.9% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $11M | — | $10.0K | $75.0K | $1M |
| Marge d'exploitation % | -1407.5% | — | -392752.9% | -63204.4% | -5470.7% |
| Résultat net | $-154M | $-38M | $-37M | $-47M | $-63M |
| BPA dilué | — | $-0.59 | $-0.58 | $-0.89 | $-1.23 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 6.6 | 1.9 | 6.4 | 5.7 | 7.7 |
| Ratio de liquidité réduite | 6.4 | 1.9 | 6.1 | 5.4 | 7.6 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-72M | $-31M | $-35M | $-47M | $-58M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 82 déclarants · $470.5M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 35 (+21 vs T. préc.) | 12 (+2 vs T. préc.) | 14 (-3 vs T. préc.) | 15 (+7 vs T. préc.) | +3.5M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| FMR LLC | $51 011 496 | 2 833 972 | 10,84% | Actions |
| BVF INC/IL | $49 477 734 | 2 748 763 | 10,52% | Actions |
| Fairmount Funds Management LLC | $49 461 588 | 2 747 866 | 10,51% | Actions |
| Venrock Adviser, LLC | $38 404 368 | 2 133 576 | 8,16% | Actions |
| Logos Global Management LP | $34 200 000 | 1 900 000 | 7,27% | Actions |
| FCPM III SERVICES B.V. | $30 201 336 | 1 677 852 | 6,42% | Actions |
| Balyasny Asset Management L.P. | $29 932 506 | 1 662 917 | 6,36% | Actions |
| Vestal Point Capital, LP | $29 340 000 | 1 630 000 | 6,24% | Actions |
| Opaleye Management Inc. | $23 748 318 | 1 319 351 | 5,05% | Actions |
| TANG CAPITAL MANAGEMENT LLC | $20 880 000 | 1 160 000 | 4,44% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $13 819 590 | 767 755 | 2,94% | Actions |
| MILLENNIUM MANAGEMENT LLC | $7 269 462 | 403 859 | 1,55% | Actions |
| JENNISON ASSOCIATES LLC | $6 813 126 | 378 507 | 1,45% | Actions |
| RTW INVESTMENTS, LP | $6 711 408 | 372 856 | 1,43% | Actions |
| NEXTBio Capital Management LP | $6 711 408 | 372 856 | 1,43% | Actions |
| Remedium Capital Partners, LLC | $6 502 500 | 361 250 | 1,38% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $6 056 873 | 336 411 | 1,29% | Actions |
| VANGUARD GROUP INC | $5 984 722 | 504 614 | 1,27% | Actions |
| STATE STREET CORP | $5 680 566 | 315 587 | 1,21% | Actions |
| AMERIPRISE FINANCIAL INC | $5 446 224 | 302 568 | 1,16% | Actions |
| Point72 Asset Management, L.P. | $5 400 000 | 300 000 | 1,15% | Actions |
| PERCEPTIVE ADVISORS LLC | $3 724 956 | 206 942 | 0,79% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3 398 454 | 188 803 | 0,72% | Actions |
| TWO SIGMA INVESTMENTS, LP | $3 363 732 | 186 874 | 0,71% | Actions |
| STEMPOINT CAPITAL LP | $3 282 876 | 182 382 | 0,70% | Actions |
| UBS Group AG | $3 061 674 | 170 093 | 0,65% | Actions |
| Exome Asset Management LLC | $2 299 842 | 127 769 | 0,49% | Actions |
| SECTORAL ASSET MANAGEMENT INC | $2 183 400 | 121 300 | 0,46% | Actions |
| Woodline Partners LP | $1 700 784 | 94 488 | 0,36% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $1 354 050 | 75 225 | 0,29% | Actions |
| Burkehill Global Management, LP | $1 332 000 | 74 000 | 0,28% | Actions |
| Blackstone Inc. | $1 127 646 | 62 647 | 0,24% | Actions |
| SILVERARC CAPITAL MANAGEMENT, LLC | $1 063 872 | 59 104 | 0,23% | Actions |
| Y-Intercept (Hong Kong) Ltd | $914 832 | 50 824 | 0,19% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $904 644 | 50 258 | 0,19% | Actions |
| Nuveen, LLC | $857 322 | 47 629 | 0,18% | Actions |
| Stonepine Capital Management, LLC | $720 000 | 40 000 | 0,15% | Actions |
| RHUMBLINE ADVISERS | $458 766 | 25 487 | 0,10% | Actions |
| MOORE CAPITAL MANAGEMENT, LP | $450 000 | 25 000 | 0,10% | Actions |
| Squarepoint Ops LLC | $434 988 | 24 166 | 0,09% | Actions |
| AMERICAN CENTURY COMPANIES INC | $410 490 | 22 805 | 0,09% | Actions |
| TWO SIGMA ADVISERS, LP | $385 450 | 32 500 | 0,08% | Actions |
| WELLS FARGO & COMPANY/MN | $354 600 | 19 700 | 0,08% | Actions |
| ADAR1 Capital Management, LLC | $328 950 | 18 275 | 0,07% | Actions |
| Virtus Investment Advisers, LLC | $328 644 | 18 258 | 0,07% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $319 590 | 17 755 | 0,07% | Actions |
| BANK OF MONTREAL /CAN/ | $247 806 | 13 767 | 0,05% | Actions |
| MetLife Investment Management, LLC | $230 040 | 12 780 | 0,05% | Actions |
| Bank of New York Mellon Corp | $224 892 | 12 494 | 0,05% | Actions |
| BANK OF AMERICA CORP /DE/ | $223 452 | 12 414 | 0,05% | Actions |
| Persistent Asset Partners Ltd | $197 424 | 10 968 | 0,04% | Actions |
| XTX Topco Ltd | $190 152 | 10 564 | 0,04% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $178 218 | 9 901 | 0,04% | Actions |
| CITIGROUP INC | $160 110 | 8 895 | 0,03% | Actions |
| Invesco Ltd. | $154 980 | 8 610 | 0,03% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $136 800 | 7 600 | 0,03% | Actions |
| BlackRock, Inc. | $119 484 | 6 638 | 0,03% | Actions |
| Police & Firemen's Retirement System of New Jersey | $114 642 | 6 369 | 0,02% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $84 600 | 4 700 | 0,02% | Actions |
| NORTHERN TRUST CORP | $61 128 | 3 396 | 0,01% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $59 454 | 3 303 | 0,01% | Actions |
| MARSHALL WACE, LLP | $59 130 | 3 285 | 0,01% | Actions |
| BARCLAYS PLC | $54 648 | 3 036 | 0,01% | Actions |
| Vanguard Global Advisers, LLC | $48 852 | 2 714 | 0,01% | Actions |
| Legal & General Group Plc | $37 746 | 2 097 | 0,01% | Actions |
| Tower Research Capital LLC (TRC) | $31 500 | 1 750 | 0,01% | Actions |
| Russell Investments Group, Ltd. | $31 068 | 1 726 | 0,01% | Actions |
| ROYAL BANK OF CANADA | $12 000 | 661 | 0,00% | Actions |
| US BANCORP \DE\ | $7 254 | 403 | 0,00% | Actions |
| Parallel Advisors, LLC | $4 752 | 264 | 0,00% | Actions |
| PRICE T ROWE ASSOCIATES INC /MD/ | $4 488 | 249 312 | 0,00% | Actions |
| Allworth Financial LP | $2 898 | 161 | 0,00% | Actions |
| Sterling Capital Management LLC | $1 368 | 76 | 0,00% | Actions |
| SBI Securities Co., Ltd. | $1 224 | 68 | 0,00% | Actions |
| JPMORGAN CHASE & CO | $1 206 | 67 | 0,00% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $900 | 50 | 0,00% | Actions |
| MORGAN STANLEY | $792 | 44 | 0,00% | Actions |
| Fortitude Family Office, LLC | $720 | 40 | 0,00% | Actions |
| Quarry LP | $522 | 29 | 0,00% | Actions |
| OSAIC HOLDINGS, INC. | $468 | 26 | 0,00% | Actions |
| Caitong International Asset Management Co., Ltd | $378 | 21 | 0,00% | Actions |
| NATIONAL BANK OF CANADA /FI/ | $54 | 3 | 0,00% | Actions |
Initiés de la société 33 initiés · 15 dirigeants · 18 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Joshua T Brumm | Chief Executive Officer | 22 juin 2026 S | 281 212 | 0 | 1 | $-761 067 |
| Harout Semerjian | Chief Executive Officer | 12 janvier 2024 A | 25 000 | 0 | 0 | $0 |
| Richard William Scalzo | Chief Financial Officer | 22 juin 2026 S | 20 298 | 0 | 1 | $-20 005 |
| Brian M. Hahn | SVP Finance, CFO | 12 janvier 2024 A | 53 143 | 0 | 0 | $0 |
| Jonathan Mcneill | President and COO | 22 juin 2026 S | 139 158 | 0 | 1 | $-369 677 |
| Jan Pinkas | Chief Scientific Officer | 22 juin 2026 S | 22 239 | 0 | 1 | $-23 171 |
| Barbara Harlin Bispham | General Counsel and Corporate Secretary. | 22 juin 2026 S | 19 330 | 0 | 1 | $-21 912 |
| Ellie Eunkyung Im | Chief Medical Officer | 22 juin 2026 S | 22 069 | 0 | 1 | $-21 930 |
| Ryan Lynch | Treasurer, Senior Vice President of Finance and Chief Accounting Officer. | 22 juin 2026 S | 13 871 | 0 | 1 | $-8 365 |
| Bruce S Johnson | SVP & Chief Commercial Officer | 12 janvier 2024 A | 138 980 | 0 | 0 | $0 |
| Chinmaya Rath | SVP and Chief Business Officer | 12 janvier 2024 A | — | 0 | 0 | $0 |
| Edwin Rock | Chief Medical Officer | 12 janvier 2024 A | 375 403 | 0 | 0 | $0 |
| Armand Girard | SVP, Chief Business Officer | 11 novembre 2022 P | 29 161 | 0 | 0 | $0 |
| John L. Magnani | SVP of Research, CSO | 11 novembre 2022 P | 366 078 | 0 | 0 | $0 |
| Helen M. Thackray | SVP Clinical Development, CMO | 20 janvier 2021 A | 183 115 | 0 | 0 | $0 |
| Alexandra Balcom | Administrateur | 2 juin 2026 A | — | 0 | 0 | $0 |
| Susan Moran | Administrateur | 2 juin 2026 A | — | 0 | 0 | $0 |
| Jonathan Violin | Administrateur | 2 juin 2026 A | — | 0 | 0 | $0 |
| David Charles Lubner | Administrateur | 2 juin 2026 A | — | 0 | 0 | $0 |
| Rachel K. King | Administrateur | 29 décembre 2023 A | 511 860 | 0 | 0 | $0 |
| Mark Alan Goldberg | Administrateur | 29 décembre 2023 A | 20 244 | 0 | 0 | $0 |
| Patricia S Andrews | Administrateur | 29 décembre 2023 A | 58 608 | 0 | 0 | $0 |
| Scott Koenig | Administrateur | 1 juin 2023 M | 36 750 | 0 | 0 | $0 |
| Scott Thomas Jackson | Administrateur | 19 mai 2023 A | 5 250 | 0 | 0 | $0 |
| Timothy R Pearson | Administrateur | 19 mai 2023 A | 24 650 | 0 | 0 | $0 |
| JUNIUS DANIEL M | Administrateur | 19 mai 2023 A | 93 250 | 0 | 0 | $0 |
| James M Barrett | Administrateur | 18 mai 2018 A | 4 995 664 | 0 | 0 | $0 |
| John J. Baldwin | Administrateur | 29 juin 2016 M | 1 210 | 0 | 0 | $0 |
| Franklin H Top JR | Administrateur | 17 mai 2016 A | 12 294 | 0 | 0 | $0 |
| Michael A Henos | Administrateur | 15 juillet 2015 A | 469 454 | 0 | 0 | $0 |
| William M. Gust | Administrateur | 15 janvier 2014 C | 409 947 | 0 | 0 | $0 |
| Scott D. Sandell | Détenteur de 10% | 26 janvier 2023 S | 2 237 196 | 0 | 0 | $0 |
| Peter J Barris | Détenteur de 10% | 10 mai 2018 X | 4 995 664 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 4 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Harwin, Tomas Kiselak ×3 dépôts | 20 juillet 2026 | 16,52% | Amendement | Investissement passif | SEC |
| Adage Capital Management, L.P., Robert Atchinson, Phillip Gross ×2 dépôts | 20 juin 2025 | 0,37% | Amendement | — | SEC |
| 8 mai 2024 | — | Dépôt initial | — | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates 13, L.P., NEA Partners 13, L.P., NEA 13 GP, LTD, Anthony A. Florence, Jr, Mohamad H. Makhzoumi, Scott D. Sandell ×4 dépôts | 29 février 2024 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 10 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0,08% | 73 362 SH | 8 août 2026 | Quotidien |
| IWO · iShares Trust | 0,02% | 197 875 SH | 8 août 2026 | Quotidien |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 23 282 SH | 8 août 2026 | Quotidien |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 15 612 NS | 31 mai 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 529 441 SH | 8 août 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 124 281 SH | 8 août 2026 | Quotidien |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 83 801 SH | 8 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 661 946 SH | 8 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 832 SH | 8 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,00% | 39 408 SH | 8 août 2026 | Quotidien |